You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic or incurable locally advanced cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Recurrent Vulvar Cancer
  • +3 more
  • (no location specified)
Jun 12, 2023

Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

Recruiting
  • Differentiated Thyroid Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 9, 2023

Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

Recruiting
  • Cancer
  • +11 more
  • San Antonio, Texas
    South Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023

Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX treatment
  • (no location specified)
Aug 9, 2023

Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 7, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)

Not yet recruiting
  • Locally Advanced or Metastatic Breast Cancer
  • SPH4336 Tablets
  • SPH4336 Tablets Placebo
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023

Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

Not yet recruiting
  • Metastatic Hepatocellular Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2023

Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 12, 2023

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

NSCLC Trial (Sutetinib Maleate Capsule)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Sutetinib Maleate Capsule
  • (no location specified)
Aug 18, 2023

Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)

Not yet recruiting
  • Locally Advanced Solid Tumors
  • +2 more
  • (no location specified)
Sep 4, 2023

Quality of Life, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Cancer Trial (ARACOMPLEX®, )

Not yet recruiting
  • Quality of Life
  • +2 more
  • ARACOMPLEX®
  • placebo
  • (no location specified)
Nov 28, 2022

NSCLC Trial in Guangzhou (BL-M07D1)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 1, 2023

NSCLC Trial in Shanghai (SI-B001, SI-B003)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

Colorectal Cancer Trial (Pembrolizumab)

Recruiting
  • Colorectal Cancer
  • Amsterdam, Netherlands
    Netherlands Cancer Institute
Jan 3, 2023

Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • (no location specified)
May 8, 2023

GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

Not yet recruiting
  • Salivary Gland Cancer
  • Observation
  • (no location specified)
Oct 13, 2023

Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)

Recruiting
  • Protein Kinase Inhibitors
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Nov 9, 2023

Locally Advanced or Metastatic NSCLC Trial (Utidelone Injection, Docetaxel Injection)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Utidelone Injection
  • Docetaxel Injection
  • (no location specified)
Dec 30, 2022

Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Trastuzumab Deruxtecan
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jul 12, 2023

Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

Recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Mar 28, 2023

Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 22, 2023

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Brussels, Barcelona, Madrid (JK08)

Recruiting
  • Cancer
  • +6 more
  • Brussels, Belgium
  • +3 more
Jan 30, 2023